Michael Aaron Kelly - Insider Trading & Ownership

Entity
Individual
Location
C/O Hookipa Pharma Inc., 430 East 29 Th St., New York, NY
Summary
The estimated net worth of Michael Aaron Kelly is at least $1.68M dollars as of August 13, 2024. Michael Aaron Kelly is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $693K. Michael Aaron Kelly is the Director of AMICUS THERAPEUTICS, INC. and owns shares of AMICUS THERAPEUTICS, INC. (FOLD) stock worth about $521K. Michael Aaron Kelly is the Director of DMC Global Inc. and owns shares of DMC Global Inc. (BOOM) stock worth about $448K. Michael Aaron Kelly is the Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $17K.
All Insider Reports
All Insider Reports

Ownership of Michael Aaron Kelly

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NEO NEOGENOMICS INC Director $693K Aug 10, 2024
FOLD AMICUS THERAPEUTICS, INC. Director $521K Jun 6, 2024
BOOM DMC Global Inc. Director $448K May 15, 2024
APRE Aprea Therapeutics, Inc. Director $17K Jun 30, 2021
HOOK HOOKIPA Pharma Inc. Director Jun 30, 2022
PRME Prime Medicine, Inc. Director Jun 12, 2024

Insider Transactions Reported by Michael Aaron Kelly:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.